Skip to main content
NAUT logo

NAUT · Nautilus Biotechnology, Inc. · Metrics

Track NAUT — free
$2.31 -0.02 (-0.65%) Play latest call Q3 2026 earnings call transcript
Market Cap
$295.50M
Shares
127.37M
Volume · Nov 16 1.75M Avg daily vol (3M) 5.87M

NAUT metrics

65 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$2.32
Market cap
$295.50M

Price action

23 metrics
Price change (1W)
+4.0%
Price change (30D)
+12.6%
Price change (3M)
+160.1%
Price change (6M)
-7.6%
Price change (YTD)
+19.0%
Price change (1Y)
+22.8%
Trailing year
Price change (5Y)
-55.3%
52-week high
$3.95
52-week low
$0.85
Change from 52-week high
-41.3%
Change from 52-week low
+172.4%
Annualized volatility
117.1%
Annualized volatility (3M)
158.4%
Implied volatility (30D)
144.6%
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
1.5
RSI (14D)
50.6
Price vs SMA 50
+24.0%
Price vs SMA 200
+8.9%
Avg volume (3M)
5.87M
Relative volume
0.3
Average dollar volume
$12.67M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
127.37M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
2.5
reciprocal yield 39.4%
FCF yield
-18.7%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-19.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-10-27

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
−$58.58M
Trailing 12 months
Diluted EPS (TTM)
$-0.46
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$-0.46
Operating cash flow per diluted share (TTM)
$-0.41
Free cash flow per diluted share (TTM)
$-0.43
Capital expenditures per diluted share (TTM)
$0.02
R&D per diluted share (TTM)
$0.31
Stock compensation per diluted share (TTM)
$0.04
Book value per share
$1.24

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.7%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-50.3%
Return on assets
-39.3%
Debt / equity
—
Current ratio
9.2
EBITDA (TTM)
—
Free cash flow (TTM)
−$55.13M
Quick ratio
9.2
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$10.47M
Latest balance sheet
Cash & equivalents
$10.47M
Total assets
$148.92M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$52.48M
Capital expenditures (TTM)
$2.65M
R&D (TTM)
$39.07M
SG&A (TTM)
—
Stock compensation (TTM)
$5.28M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
93
13F filer change QoQ
+12
Institutional ownership
39.4%
Conviction holders (share of 13F filers)
1.1%
Crowding (high-turnover and private-fund holders)
27.3%
Private-fund adviser ownership
26.2%
Active holders' share change QoQ
-16.4%
Holder tenure
12.9
Price vs estimated holder cost
-65.7%

Ownership (registered funds)

1 metrics
Index-fund ownership
4.0%

Short interest

3 metrics
Short interest
4.6%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
56 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1808805 CUSIP 63909J108 13F (30d) 65 filings 54 filers Visit website Investor relations